Superior boosting of neutralizing titers against Omicron SARS-CoV-2 variants by heterologous SCB-2019 vaccine vs a homologous booster in CoronaVac-primed adults. (PubMed, J Infect Dis) - Jul 13, 2023 - "Boosting CoronaVac-immunized adults with full or half doses of SCB-2019 was well tolerated with superior immunogenicity than homologous boosting, particularly against newly emerged variants, supporting use of SCB-2019 for booster vaccination."
Journal • Fatigue • Infectious Disease • Novel Coronavirus Disease • Pain • Respiratory Diseases
|
|
Branda Hu; Camilo C Roa; Donna Ambrosino; Eric Plennevaux; Faith Gao; George Siber; Hannalyn Ilagan; Igor Smolenov; Mari Rose A de Los Reyes; Ralf Clemens
|